Search research articles
Contact Us
Filters
Showing results (91-100 of 379) with videos related to
Page
of 38
Sort By:
Drugs
|
January 22, 2025
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight
Antonella Cammarota, Rachel Woodford, Elizabeth C Smyth
International Journal of Pharmaceutics
|
September 7, 2010
Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations
Martin J Donovan, Hugh D C Smyth
Oncotargets and Therapy
|
August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
Michael Davidson, Elizabeth C Smyth, David Cunningham
Drug Development and Industrial Pharmacy
|
October 30, 2016
Implementation of design of experiments approach for the micronization of a drug with a high brittle-ductile transition particle diameter
Ashkan K Yazdi, Hugh D C Smyth
AAPS Pharmscitech
|
November 19, 2003
Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers
Hugh D C Smyth, Anthony J Hickey
The Lancet. Gastroenterology & Hepatology
|
April 5, 2020
A global perspective on oesophageal cancer: two diseases in one
Andrew L K Ho, Elizabeth C Smyth
ESMO Open
|
January 20, 2024
Controversies in upper GI oncology: MSI-H in gastroesophageal adenocarcinoma
A Petrillo, S Derks, E C Smyth
International Journal of Pharmaceutics
|
June 29, 2016
Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance
Ashkan K Yazdi, Hugh D C Smyth
Current Treatment Options in Oncology
|
April 2, 2016
Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?
Elisa Fontana, Elizabeth C Smyth, David Cunningham
Archives Internationales De Pharmacodynamie Et De Therapie
|
May 1, 1987
The action of dopamine upon glycerol and fatty acid release by rat brown adipose tissue
G M Maxwell, S Crompton, C Smyth
Page
of 38
Search research articles
Search
Showing results (91-100 of 379) with videos related to
Sort By:
Page
of 38
Drugs
|
January 22, 2025
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight
Antonella Cammarota, Rachel Woodford, Elizabeth C Smyth
International Journal of Pharmaceutics
|
September 7, 2010
Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations
Martin J Donovan, Hugh D C Smyth
Oncotargets and Therapy
|
August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
Michael Davidson, Elizabeth C Smyth, David Cunningham
Drug Development and Industrial Pharmacy
|
October 30, 2016
Implementation of design of experiments approach for the micronization of a drug with a high brittle-ductile transition particle diameter
Ashkan K Yazdi, Hugh D C Smyth
AAPS Pharmscitech
|
November 19, 2003
Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers
Hugh D C Smyth, Anthony J Hickey
The Lancet. Gastroenterology & Hepatology
|
April 5, 2020
A global perspective on oesophageal cancer: two diseases in one
Andrew L K Ho, Elizabeth C Smyth
ESMO Open
|
January 20, 2024
Controversies in upper GI oncology: MSI-H in gastroesophageal adenocarcinoma
A Petrillo, S Derks, E C Smyth
International Journal of Pharmaceutics
|
June 29, 2016
Carrier-free high-dose dry powder inhaler formulation of ibuprofen: Physicochemical characterization and in vitro aerodynamic performance
Ashkan K Yazdi, Hugh D C Smyth
Current Treatment Options in Oncology
|
April 2, 2016
Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?
Elisa Fontana, Elizabeth C Smyth, David Cunningham
Archives Internationales De Pharmacodynamie Et De Therapie
|
May 1, 1987
The action of dopamine upon glycerol and fatty acid release by rat brown adipose tissue
G M Maxwell, S Crompton, C Smyth
Page
of 38